Harrow New York — an offshoot of a famed British boarding school — will lower tuition to $50,544 for day students from ...

Harrow recently experienced a 24% share price increase over the last quarter, coinciding with its announcement of a $250 million debt financing via senior unsecured notes. This announcement comes at a ...

Shares of Harrow rose after the company reaffirmed its full-year guidance for revenue between $270 million and $280 million. Shares were trading up 6.9% to $43.76 Monday morning The stock has gained ...

Boll stated, "we are updating our full year revenue outlook to a range of $270 million to $280 million." He noted, "While our original target is still within reach, this new range is one I believe we ...

Doubling of VEVYE® Sales Force is On Track, Expansion of IHEEZO® Commercial Footprint to the Office-Based Setting Underway, and Doubling TRIESENCE® Commercial Footprint in the Surgical-Based Setting ...

Harrow's stock is down 17% since my last analysis and "Sell" recommendation. Harrow's Q4 and FY24 results show significant revenue growth and improved net income, but the company faces complex ...

Please provide your email address to receive an email when new articles are posted on . Harrow will inherit MELT-300, a sublingually delivered sedation product. The company plans to submit a new drug ...

Eyecare pharmaceutical company Harrow Health is expanding its Nashville corporate headquarters in a $3 million investment that is slated to bring 147 new jobs to the city. Harrow announced the move ...